Evidence map›Paper›PMID 11289469›Full record

Trial reportDiabetes care2001

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

R C Perry, R R Shankar, N Fineberg, J McGill, A D Baron, Early Diabetes Intervention Program (EDIP)

Open access · bronzeAbstract readClinical TrialComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Diabetes care, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019
    Article
  14. Review
  15. TheInternational journal of molecular sciences · 2018
    Article
  16. Diabetes in Immigrant Tibetan Muslims in Kashmir, North India.Journal of immigrant and minority health · 2018
    Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

R C PerryDepartment of Medicine, Indiana University, Indianapolis, USA.
R R Shankar
N Fineberg
J McGill
A D Baron
Early Diabetes Intervention Program (EDIP)
Indiana University – Purdue University Indianapolis · USPediatrics and Genetics · USRichard L. Roudebush VA Medical Center · USWashington University in St. Louis · US

Funding

THE CLINTON COUNTY OUTREACH PROJECT (CCOP)P60DK020542 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CLARK, CHARLES MALCOLM · 1986 to 2003
$5.1M
NCRR NIH HHS MO1-RR750-19NIDDK NIH HHS DK-20542
6 · The paper itself

Abstract

objectiveWhereas new diagnostic criteria based on a fasting plasma glucose (FPG) of > 126 mg/dl (7.8 mmol/l) have improved the detection of diabetes, multiple reports indicate that many people with diabetes diagnosed by 2-h oral glucose tolerance test (OGTT) glucose measurements > or = 11.1 mmol/l (200 mg/dl) would remain undiagnosed based on this FPG criteria. Thus, improved methods to detect diabetes are particularly needed for high-risk individuals. We evaluated whether the combination of FPG and HbA1c measurements enhanced detection of diabetes in those individuals at risk for diabetes with nondiagnostic or minimally elevated FPG. RESEARCH DESIGN AND

methodsWe analyzed FPG, OGTT, and HbA1c data from 244 subjects screened for participation in the Early Diabetes Intervention Program (EDIP).

resultsOf 244 high-risk subjects studied by FPG measurements and OGTT, 24% of the individuals with FPG levels of 5.5-6.0 mmol/l (100-109 mg/dl) had OGTT-diagnosed diabetes, and nearly 50% of the individuals with FPG levels of 6.1-6.9 mmol/l (110-125 mg/dl) had OGTT-diagnosed diabetes. In the subjects with OGTT-diagnosed diabetes and FPG levels between 5.5 and 8.0 mmol/l, detection of an elevated HbA1c (>6.1% or mean + 2 SDs) led to a substantial improvement in diagnostic sensitivity over the FPG threshold of 7.0 mmol/l (61 vs. 45%, respectively, P = 0.002). Concordant FPG levels > or = 7.0 mmol/l (currently recommended for diagnosis) occurred in only 19% of our cohort with type 2 diabetes.

conclusionsDiagnostic criteria based on FPG criteria are relatively insensitive in the detection of early type 2 diabetes in at-risk subjects. HbA1c measurement improves the sensitivity of screening in high-risk individuals.

Indexed as

BiomarkersBlood GlucoseDiabetes Mellitus, Type 2Double-Blind MethodEthnicityFastingFemaleGlucose Tolerance TestGlycated HemoglobinHumansMaleMiddle AgedMonitoring, PhysiologicRacial GroupsRegression AnalysisRisk FactorsBiomarkersBlood GlucoseGlycated Hemoglobin

Identifiers

PMID11289469
OpenAlexW2023807105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.